Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q3 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.